MiniMed grants Kevin E. Lofton 11,795 stock units

The award is scheduled to vest on the one-year anniversary of its grant date under the company's 2026 Long Term Incentive Plan.

Rhea-AI Filing Summary

MiniMed Group, Inc. (MMED) director Kevin E. Lofton received a grant of 11,795 restricted stock units on October 9, 2026, under the 2026 MiniMed Group, Inc. Long Term Incentive Plan. The RSUs vest on the one-year anniversary of the grant date. His reported direct post-transaction position was 39,573 shares of common stock, including shares to be issued in connection with the vesting of one or more RSUs.

Insider Trade Summary

Grant/Award: 11,795 shares

Grant/Award 1 txn

Insider Lofton Kevin E

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1, F2	11,795	$0.00	$0.00

Holdings After Transaction: Common Stock — 39,573 shares (Direct)

Footnotes (2)

1. F1. Represents the grant of restricted stock units ("RSUs") pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan that vest on the one-year anniversary of the grant date.
2. F2. Includes shares of common stock to be issued in connection with the vesting of one or more RSUs.

Key Figures

Restricted stock units granted: 11,795 restricted stock units Direct shares after transaction: 39,573 shares of common stock Vesting schedule: One-year anniversary of grant date

3 metrics

Restricted stock units granted 11,795 restricted stock units Grant dated October 9, 2026

Direct shares after transaction 39,573 shares of common stock Includes shares to be issued in connection with vesting of one or more RSUs

Vesting schedule One-year anniversary of grant date Applies to the RSUs granted

Key Terms

restricted stock units, vesting, Long Term Incentive Plan

3 terms

restricted stock units financial

"grant of restricted stock units ("RSUs")"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

vesting financial

"shares of common stock to be issued in connection with the vesting"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

Long Term Incentive Plan financial

"pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan"

A long term incentive plan is a company program that awards executives and key employees bonuses—often in stock, options, or cash—only if the business meets multi-year performance goals. It links management pay to company results—like tying a coach’s bonus to a team’s multi-season record—so investors monitor it for how leaders are motivated, potential share dilution, and signals about the company’s long-term priorities.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many RSUs did MiniMed Group (MMED) director Kevin E. Lofton receive?

Kevin E. Lofton received 11,795 restricted stock units on October 9, 2026, under the 2026 MiniMed Group, Inc. Long Term Incentive Plan. The RSUs vest on the one-year anniversary of the grant date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/13/2026 - 06:13 PM EDT Accepted by SEC EDGAR 10/13/2026 - 06:13 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lofton Kevin E

(Last) (First) (Middle)

C/O MINIMED GROUP, INC.

18000 DEVONSHIRE STREET

(Street)

NORTHRIDGE CALIFORNIA 91325

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MiniMed Group, Inc. [ MMED ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/09/2026		A		11,795(1)	A	$0	39,573(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the grant of restricted stock units ("RSUs") pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan that vest on the one-year anniversary of the grant date.

2. Includes shares of common stock to be issued in connection with the vesting of one or more RSUs.

Remarks:

	/s/ Bryan F. Kelly, attorney-in-fact	10/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)